Literature DB >> 26632069

Air-kerma strength determination of a new directional (103)Pd source.

Manik Aima1, Joshua L Reed1, Larry A DeWerd1, Wesley S Culberson1.   

Abstract

PURPOSE: A new directional (103)Pd planar source array called a CivaSheet™ has been developed by CivaTech Oncology, Inc., for potential use in low-dose-rate (LDR) brachytherapy treatments. The array consists of multiple individual polymer capsules called CivaDots, containing (103)Pd and a gold shield that attenuates the radiation on one side, thus defining a hot and cold side. This novel source requires new methods to establish a source strength metric. The presence of gold material in such close proximity to the active (103)Pd region causes the source spectrum to be significantly different than the energy spectra of seeds normally used in LDR brachytherapy treatments. In this investigation, the authors perform air-kerma strength (S(K)) measurements, develop new correction factors for these measurements based on an experimentally verified energy spectrum, and test the robustness of transferring S(K) to a well-type ionization chamber.
METHODS: S(K) measurements were performed with the variable-aperture free-air chamber (VAFAC) at the University of Wisconsin Medical Radiation Research Center. Subsequent measurements were then performed in a well-type ionization chamber. To realize the quantity S(K) from a directional source with gold material present, new methods and correction factors were considered. Updated correction factors were calculated using the MCNP 6 Monte Carlo code in order to determine S(K) with the presence of gold fluorescent energy lines. In addition to S(K) measurements, a low-energy high-purity germanium (HPGe) detector was used to experimentally verify the calculated spectrum, a sodium iodide (NaI) scintillating counter was used to verify the azimuthal and polar anisotropy, and a well-type ionization chamber was used to test the feasibility of disseminating S(K) values for a directional source within a cylindrically symmetric measurement volume.
RESULTS: The UW VAFAC was successfully used to measure the S(K) of four CivaDots with reproducibilities within 0.3%. Monte Carlo methods were used to calculate the UW VAFAC correction factors and the calculated spectrum emitted from a CivaDot was experimentally verified with HPGe detector measurements. The well-type ionization chamber showed minimal variation in response (<1.5%) as a function of source positioning angle, indicating that an American Association of Physicists in Medicine (AAPM) Accredited Dosimetry Calibration Laboratory calibrated well chamber would be a suitable device to transfer an S(K)-based calibration to a clinical user. S(K) per well-chamber ionization current ratios were consistent among the four dots measured. Additionally, the measurements and predictions of anisotropy show uniform emission within the solid angle of the VAFAC, which demonstrates the robustness of the S(K) measurement approach.
CONCLUSIONS: This characterization of a new (103)Pd directional brachytherapy source helps to establish calibration methods that could ultimately be used in the well-established AAPM Task Group 43 formalism. Monte Carlo methods accurately predict the changes in the energy spectrum caused by the fluorescent x-rays produced in the gold shield.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26632069      PMCID: PMC5148138          DOI: 10.1118/1.4935409

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  14 in total

1.  Development of an adjoint sensitivity field-based treatment-planning technique for the use of newly designed directional LDR sources in brachytherapy.

Authors:  V Chaswal; B R Thomadsen; D L Henderson
Journal:  Phys Med Biol       Date:  2012-02-01       Impact factor: 3.609

2.  Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer.

Authors:  George Voynov; Dwight E Heron; Chyongchiou J Lin; Steven Burton; Alex Chen; Annette Quinn; Ricardo Santos; Athanasios Colonias; Rodney J Landreneau
Journal:  Brachytherapy       Date:  2005       Impact factor: 2.362

3.  Supplement to the 2004 update of the AAPM Task Group No. 43 Report.

Authors:  Mark J Rivard; Wayne M Butler; Larry A DeWerd; M Saiful Huq; Geoffrey S Ibbott; Ali S Meigooni; Christopher S Melhus; Michael G Mitch; Ravinder Nath; Jeffrey F Williamson
Journal:  Med Phys       Date:  2007-06       Impact factor: 4.071

4.  The use of directional interstitial sources to improve dosimetry in breast brachytherapy.

Authors:  Liyong Lin; Rakesh R Patel; Bruce R Thomadsen; Douglass L Henderson
Journal:  Med Phys       Date:  2008-01       Impact factor: 4.071

5.  Primary calibration of coiled 103Pd brachytherapy sources.

Authors:  Adam B Paxton; Wesley S Culberson; Larry A DeWerd; John A Micka
Journal:  Med Phys       Date:  2008-01       Impact factor: 4.071

6.  Experimental and Monte Carlo dosimetric characterization of a 1 cm (103)Pd brachytherapy source.

Authors:  Joshua L Reed; Mark J Rivard; John A Micka; Wesley S Culberson; Larry A DeWerd
Journal:  Brachytherapy       Date:  2014-05-28       Impact factor: 2.362

7.  Evaluation of brachytherapy lung implant dose distributions from photon-emitting sources due to tissue heterogeneities.

Authors:  Yun Yang; Mark J Rivard
Journal:  Med Phys       Date:  2011-11       Impact factor: 4.071

8.  Evaluation of the new cesium-131 seed for use in low-energy x-ray brachytherapy.

Authors:  Mark K Murphy; R Kim Piper; Lawrence R Greenwood; Michael G Mitch; Paul J Lamperti; Stephen M Seltzer; Matt J Bales; Mark H Phillips
Journal:  Med Phys       Date:  2004-06       Impact factor: 4.071

9.  Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer.

Authors:  Ricardo Santos; Athanasios Colonias; David Parda; Mark Trombetta; Richard H Maley; Robin Macherey; Susan Bartley; Tibetha Santucci; Robert J Keenan; Rodney J Landreneau
Journal:  Surgery       Date:  2003-10       Impact factor: 3.982

10.  New National Air-Kerma-Strength Standards for (125)I and (103)Pd Brachytherapy Seeds.

Authors:  Stephen M Seltzer; Paul J Lamperti; Robert Loevinger; Michael G Mitch; James T Weaver; Bert M Coursey
Journal:  J Res Natl Inst Stand Technol       Date:  2003-10-01
View more
  5 in total

1.  Dosimetric characterization of a new directional low-dose rate brachytherapy source.

Authors:  Manik Aima; Larry A DeWerd; Michael G Mitch; Clifford G Hammer; Wesley S Culberson
Journal:  Med Phys       Date:  2018-05-24       Impact factor: 4.071

2.  Intraoperative implantation of a mesh of directional palladium sources (CivaSheet): Dosimetry verification, clinical commissioning, dose specification, and preliminary experience.

Authors:  Gil'ad N Cohen; Karen Episcopia; Seng-Boh Lim; Thomas J LoSasso; Mark J Rivard; Amandeep S Taggar; Neil K Taunk; Abraham J Wu; Antonio L Damato
Journal:  Brachytherapy       Date:  2017-08-18       Impact factor: 2.362

3.  A directional 103Pd brachytherapy device: Dosimetric characterization and practical aspects for clinical use.

Authors:  Mark J Rivard
Journal:  Brachytherapy       Date:  2016-12-28       Impact factor: 2.362

4.  Report of the First Patient Treated for Pelvic Sarcoma With a Directional 103Pd Brachytherapy Device.

Authors:  Serguei A Castaneda; Marian Khalili; Jacqueline Emrich; Veronica M Zoghbi; Michael S Weingarten; Mark J Rivard; Wilbur B Bowne; Jaganmohan Poli
Journal:  Adv Radiat Oncol       Date:  2019-07-26

5.  The CivaSheet: The new frontier of intraoperative radiation therapy or a pricier alternative to LDR brachytherapy?

Authors:  Danushka Seneviratne; Christopher McLaughlin; Dorin Todor; Brian Kaplan; Emma C Fields
Journal:  Adv Radiat Oncol       Date:  2017-10-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.